HCM · LONDON STOCK EXCHANGE ·
HUTCHMED China Ltd
China NMPA Approval of SYVIK
Our AI’s take
HUTCHMED announced simultaneous China NMPA approvals for SYVIK in adults with chronic primary ITP who had an insufficient response to at least one prior…
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.